treatment fallopian tube carcinoma cisplatin doxorubicin cyclophosphamid primari carcinoma fallopian tube uncommon regimen activ ovarian carcinoma evid scant therapi patient fallopian tube carcinoma between decemb juli patient adenocarcinoma fallopian tube combin cisplatin doxorubicin cyclophosphamid day day histolog confirm fallopian tube carcinoma entri studi patient stage stage II stage iii stage IV sixteen patient combin therapi first-lin treatment cytoreduct surgeri patient recurr carcinoma seven patient measur diseas start therapi patient complet clinic respons stabl diseas progress diseas patient stage ii-iv diseas underw second-look laparotomi complet respons partial respons overal respons rate toxic regimen moder median surviv month patient stage ii-iv diseas median surviv month progression-fre surviv month regimen activ fallopian tube carcinoma respons rate compar epitheli ovarian cancer 